Sreenivasa Nattam

5.0k citations
42 papers · 2.6k indexed · 1 hit paper · h-index 20

Sreenivasa Nattam

42 papers receiving 2.6k citations

Hit Papers

Combination cediranib and olaparib versus olaparib alone ...4462014202620182022100200300400

Peers

Sreenivasa Nattam
Comparison fields: 5 of 83
  • Oncology 1.9k
  • Reproductive Medicine 418
  • Otorhinolaryngology 211
  • Pulmonary and Respiratory Medicine 1.0k
  • Cancer Research 378
Replace Sanatan Saraf with:
Sanatan Saraf United States
Eirini Pectasides Greece
Vera Gorbounova Russia
Pavlos Papakostas Greece
Annamaria H. Zimmermann United States
V.A. Miller United States
Karin Bowen United States
Vincent van der Noort Netherlands
D. Fennelly Ireland
Paul T. Fanta United States
Sreenivasa Nattam relative to Sanatan Saraf United States Sanatan Saraf's profile →
Citations per field
00.5×3.8×
Sanatan Saraf · 1×
Citations per year

Countries citing papers authored by Sreenivasa Nattam

Since Specialization
Citations

This map shows the geographic impact of Sreenivasa Nattam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sreenivasa Nattam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sreenivasa Nattam more than expected).

Fields of papers citing papers by Sreenivasa Nattam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sreenivasa Nattam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sreenivasa Nattam. The network helps show where Sreenivasa Nattam may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sreenivasa Nattam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sreenivasa Nattam Line = papers co-authored together Sreenivasa Nattam links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202121
2 202110
3
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 studybreakdown →
2014446
4 201457
5 201414
6 201217
7 201288
8 2011147
9 201023
10 201087
11 200912
12 200925
13 20085
14 200711
15 200610
16 200438
17 20044
18 20042
19 20031
20 200014

About Sreenivasa Nattam

Sreenivasa Nattam is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 42 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Research Studies (8 papers), Cancer Genomics and Diagnostics (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Ovarian cancer diagnosis and treatment (5 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (1.9k citations), Reproductive Medicine (418 citations) and Otorhinolaryngology (211 citations). Sreenivasa Nattam has collaborated with scholars based in United States, Australia and India. Frequent co-authors include Everett E. Vokes, Hedy L. Kindler, Walter M. Stadler, Mark Kozloff, Gershon Y. Locker, Theodore Karrison, D. A. Singh, Gregory Friberg, Mary K. Buss and Ronald J. Buckanovich. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026